PYRAMID AG (M3B.DE) Fundamental Analysis & Valuation

FRA:M3B • DE000A40ZWM7

0.698 EUR
0 (-0.29%)
Last: Mar 10, 2026, 01:04 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This M3B.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, M3B scores 2 out of 10 in our fundamental rating. M3B was compared to 34 industry peers in the Technology Hardware, Storage & Peripherals industry. M3B may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, M3B is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. M3B.DE Profitability Analysis

1.1 Basic Checks

  • M3B had negative earnings in the past year.
  • In multiple years M3B reported negative net income over the last 5 years.
  • M3B had a negative operating cash flow in each of the past 5 years.
M3B.DE Yearly Net Income VS EBIT VS OCF VS FCFM3B.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

  • M3B has a worse Return On Assets (-0.29%) than 67.65% of its industry peers.
  • M3B has a Return On Equity (-0.48%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -0.29%
ROE -0.48%
ROIC N/A
ROA(3y)2.26%
ROA(5y)-2.19%
ROE(3y)3.1%
ROE(5y)-2.17%
ROIC(3y)N/A
ROIC(5y)N/A
M3B.DE Yearly ROA, ROE, ROICM3B.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

  • The Gross Margin of M3B (-434.35%) is worse than 94.12% of its industry peers.
  • M3B's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for M3B so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM -434.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.41%
M3B.DE Yearly Profit, Operating, Gross MarginsM3B.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. M3B.DE Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for M3B has been increased compared to 1 year ago.
  • The number of shares outstanding for M3B has been increased compared to 5 years ago.
  • The debt/assets ratio for M3B is higher compared to a year ago.
M3B.DE Yearly Shares OutstandingM3B.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
M3B.DE Yearly Total Debt VS Total AssetsM3B.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • Based on the Altman-Z score of 0.23, we must say that M3B is in the distress zone and has some risk of bankruptcy.
  • M3B has a Altman-Z score of 0.23. This is in the lower half of the industry: M3B underperforms 73.53% of its industry peers.
  • A Debt/Equity ratio of 0.28 indicates that M3B is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.28, M3B is doing good in the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Altman-Z 0.23
ROIC/WACCN/A
WACCN/A
M3B.DE Yearly LT Debt VS Equity VS FCFM3B.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.3 Liquidity

  • M3B has a Current Ratio of 2.94. This indicates that M3B is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of M3B (2.94) is better than 91.18% of its industry peers.
  • M3B has a Quick Ratio of 1.08. This is a normal value and indicates that M3B is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.08, M3B is in line with its industry, outperforming 55.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 1.08
M3B.DE Yearly Current Assets VS Current LiabilitesM3B.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. M3B.DE Growth Analysis

3.1 Past

  • The earnings per share for M3B have decreased strongly by -150.00% in the last year.
  • Looking at the last year, M3B shows a very negative growth in Revenue. The Revenue has decreased by -115.30% in the last year.
  • Measured over the past years, M3B shows a very strong growth in Revenue. The Revenue has been growing by 143.51% on average per year.
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-450%
Revenue 1Y (TTM)-115.3%
Revenue growth 3Y441.32%
Revenue growth 5Y143.51%
Sales Q2Q%-19.28%

3.2 Future

  • M3B is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.00% yearly.
  • The Revenue is expected to grow by 13.54% on average over the next years. This is quite good.
EPS Next Y-140%
EPS Next 2Y89.74%
EPS Next 3Y61.34%
EPS Next 5Y39%
Revenue Next Year10.57%
Revenue Next 2Y16.56%
Revenue Next 3Y16.92%
Revenue Next 5Y13.54%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
M3B.DE Yearly Revenue VS EstimatesM3B.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 50M 100M
M3B.DE Yearly EPS VS EstimatesM3B.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. M3B.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • M3B reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for M3B. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
M3B.DE Price Earnings VS Forward Price EarningsM3B.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
M3B.DE Per share dataM3B.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • A more expensive valuation may be justified as M3B's earnings are expected to grow with 61.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y89.74%
EPS Next 3Y61.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. M3B.DE Dividend Analysis

5.1 Amount

  • No dividends for M3B!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

M3B.DE Fundamentals: All Metrics, Ratios and Statistics

PYRAMID AG

FRA:M3B (3/10/2026, 1:04:28 PM)

0.698

0 (-0.29%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)02-18
Earnings (Next)05-04
Inst Owners2.09%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.10M
Revenue(TTM)-5.99M
Net Income(TTM)-211.00K
Analysts80
Price Target1.68 (140.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.37
P/tB 1.24
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS-0.26
BVpS1.89
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.29%
ROE -0.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM -434.35%
FCFM N/A
ROA(3y)2.26%
ROA(5y)-2.19%
ROE(3y)3.1%
ROE(5y)-2.17%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-13.41%
F-ScoreN/A
Asset Turnover-0.08
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.94
Quick Ratio 1.08
Altman-Z 0.23
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-450%
EPS Next Y-140%
EPS Next 2Y89.74%
EPS Next 3Y61.34%
EPS Next 5Y39%
Revenue 1Y (TTM)-115.3%
Revenue growth 3Y441.32%
Revenue growth 5Y143.51%
Sales Q2Q%-19.28%
Revenue Next Year10.57%
Revenue Next 2Y16.56%
Revenue Next 3Y16.92%
Revenue Next 5Y13.54%
EBIT growth 1Y-350.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year294.18%
EBIT Next 3Y92.36%
EBIT Next 5Y51.68%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

PYRAMID AG / M3B.DE FAQ

Can you provide the ChartMill fundamental rating for PYRAMID AG?

ChartMill assigns a fundamental rating of 2 / 10 to M3B.DE.


What is the valuation status for M3B stock?

ChartMill assigns a valuation rating of 1 / 10 to PYRAMID AG (M3B.DE). This can be considered as Overvalued.


What is the profitability of M3B stock?

PYRAMID AG (M3B.DE) has a profitability rating of 1 / 10.